Evidence-Based Medicine Guidelines
Melphalan and prednisolone plus thalidomide compared to other treatments for multiple myeloma in the elderly
Melphalan and prednisolone plus thalidomide compared to other treatments for multiple myeloma in the elderly is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Melphalan and Prednisolone Plus Thalidomide Compared to Other Treatments for Multiple Myeloma in the Elderly." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/450033/all/Melphalan_and_prednisolone_plus_thalidomide_compared_to_other_treatments_for_multiple_myeloma_in_the_elderly.
Melphalan and prednisolone plus thalidomide compared to other treatments for multiple myeloma in the elderly. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/450033/all/Melphalan_and_prednisolone_plus_thalidomide_compared_to_other_treatments_for_multiple_myeloma_in_the_elderly. Accessed March 21, 2023.
Melphalan and prednisolone plus thalidomide compared to other treatments for multiple myeloma in the elderly. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/450033/all/Melphalan_and_prednisolone_plus_thalidomide_compared_to_other_treatments_for_multiple_myeloma_in_the_elderly
Melphalan and Prednisolone Plus Thalidomide Compared to Other Treatments for Multiple Myeloma in the Elderly [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 March 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/450033/all/Melphalan_and_prednisolone_plus_thalidomide_compared_to_other_treatments_for_multiple_myeloma_in_the_elderly.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Melphalan and prednisolone plus thalidomide compared to other treatments for multiple myeloma in the elderly
ID - 450033
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450033/all/Melphalan_and_prednisolone_plus_thalidomide_compared_to_other_treatments_for_multiple_myeloma_in_the_elderly
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
